Telehealth giant reports 2025 growth in revenue and subscribers, says 2026 weight loss business is “durable.”
In the last year and a half, direct-to-consumer telehealth company Hims & Hers has become a leading voice in the debate over compounded GLP-1 weight loss medications. On Monday, it announced earnings from the last quarter of 2025 after a whirlwind mo… [977 chars]
Source: STAT | Published: 2026-02-24T01:14:06Z
Credit: STAT
